Malignant Melanoma in Pigmented Skin: Does the Current Interventional Model Fit a Different Clinical, Histologic, and Molecular Entity?

Background Although the incidence of malignant melanoma in African Americans is considerably lower than in Caucasians, African Americans have a less‐favorable prognosis related to later presentation and more deeply invasive lesions at diagnosis. Objective To review the current literature addressing...

Full description

Saved in:
Bibliographic Details
Published in:Dermatologic surgery 2013-09, Vol.39 (9), p.1291-1303
Main Authors: Alexandrescu, Doru T., Maslin, Benjamin, Kauffman, Catherine Lisa, Ichim, Thomas E., Dasanu, Constantin A.
Format: Article
Language:English
Subjects:
African Americans
Health Status Disparities
Humans
Immunotherapy
Melanoma - ethnology
Melanoma - genetics
Melanoma - pathology
Melanoma - therapy
Prognosis
Skin Neoplasms - ethnology
Skin Neoplasms - genetics
Skin Neoplasms - pathology
Skin Neoplasms - therapy
Skin Pigmentation
United States - epidemiology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Although the incidence of malignant melanoma in African Americans is considerably lower than in Caucasians, African Americans have a less‐favorable prognosis related to later presentation and more deeply invasive lesions at diagnosis. Objective To review the current literature addressing the specific clinical, histopathologic, and molecular features of melanoma in darkly pigmented individuals. Methods We reviewed the most up‐to‐date literature pertaining to melanoma in this patient population, including data from clinical studies, epidemiologic analyses, and molecular and genetic studies. Results Several studies have suggested differences between lightly and darkly pigmented populations with regard to clinicopathologic character and the underlying genetic processes affecting its pathogenesis. Conclusion Further investigation is warranted to better elucidate the clinical and underlying biological differences in melanoma between Caucasians and African Americans. Such research may help to ameliorate the disparities in melanoma outcomes through improved screening, public health measures aimed at prevention, and potentially novel targeted therapeutic approaches.
ISSN:1076-0512
1524-4725
DOI:10.1111/dsu.12251